SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011310
Filing Date
2021-08-11
Accepted
2021-08-11 16:31:08
Documents
56
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gbio-20210630x10q.htm   iXBRL 10-Q 1375424
2 EX-31.1 gbio-20210630xex31d1.htm EX-31.1 7414
3 EX-31.2 gbio-20210630xex31d2.htm EX-31.2 7553
4 EX-32.1 gbio-20210630xex32d1.htm EX-32.1 5115
5 EX-32.2 gbio-20210630xex32d2.htm EX-32.2 5094
  Complete submission text file 0001558370-21-011310.txt   4587293

Data Files

Seq Description Document Type Size
6 EX-101.SCH gbio-20210630.xsd EX-101.SCH 27915
7 EX-101.CAL gbio-20210630_cal.xml EX-101.CAL 41993
8 EX-101.DEF gbio-20210630_def.xml EX-101.DEF 95677
9 EX-101.LAB gbio-20210630_lab.xml EX-101.LAB 256965
10 EX-101.PRE gbio-20210630_pre.xml EX-101.PRE 220374
11 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20210630x10q_htm.xml XML 674093
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

IRS No.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39319 | Film No.: 211163849
SIC: 2834 Pharmaceutical Preparations